BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neocentromeres
,
Rosiglitazone
,
rs2230926
,
SNCA
,
Fatty acid metabolic process
,
Retina
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
fibroblast growth factor receptor 1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Transverse colon
Saphenous vein
Aorta
Ovary
Coronary artery
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
The discovery of potent and stable short peptide FGFR1 antagonist for cancer therapy.
Myeloid/lymphoid neoplasm with CEP110-FGFR1 fusion: An analysis of 16 cases show common features and…
Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor.
Protein Tyrosine Phosphatase Receptor Type G (PTPRG) Controls Fibroblast Growth Factor Receptor (FGF…
Cek1 regulates ß(1,3)-glucan exposure through calcineurin effectors in Candida albicans.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alte…
A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor …
An Open-label Phase I Study of Orally Available Novel Small-molecule Fibroblast Growth Factor Recept…
Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth F…
Phase 1 Study of E7090 in Subjects With Solid Tumor
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ